An FDA panel holds a two-day review of a controversial surgical instrument. The evidence presented during the hearing only confirmed the FDA's opposition to use of the power morcellation tool, which was said to promote the spread of cancer.
An FDA panel holds a two-day review of a controversial surgical instrument. The evidence presented during the hearing only confirmed the FDA's opposition to use of the power morcellation tool, which was said to promote the spread of cancer.